flurbiprofen has been researched along with gamma-aminobutyric acid in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrews, PR; Craik, DJ; Martin, JL | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Almeida-Suhett, CP; Aroniadou-Anderjaska, V; Braga, MF; Figueiredo, TH; Miller, SL; Pidoplichko, VI; Prager, EM | 1 |
| Barchielli, M; Bettini, R; Buttini, F; Colombo, G; Colombo, P; Conti, C; Leoni, B; Loprete, L; Rossi, A; Sonvico, F | 1 |
1 trial(s) available for flurbiprofen and gamma-aminobutyric acid
| Article | Year |
|---|---|
Multi-kinetics and site-specific release of gabapentin and flurbiprofen from oral fixed-dose combination: in vitro release and in vivo food effect.
Topics: Administration, Oral; Adolescent; Adult; Amines; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Studies; Cyclohexanecarboxylic Acids; Delayed-Action Preparations; Drug Combinations; Drug Liberation; Female; Flurbiprofen; Food-Drug Interactions; GABA Agonists; Gabapentin; gamma-Aminobutyric Acid; Gastric Mucosa; Humans; Intestinal Mucosa; Male; Middle Aged; Polymers; Tablets; Young Adult | 2017 |
4 other study(ies) available for flurbiprofen and gamma-aminobutyric acid
| Article | Year |
|---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
ASIC1a activation enhances inhibition in the basolateral amygdala and reduces anxiety.
Topics: Acid Sensing Ion Channels; Action Potentials; Ammonium Compounds; Amygdala; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anxiety; Dark Adaptation; Disease Models, Animal; Excitatory Amino Acid Antagonists; Exploratory Behavior; Flurbiprofen; GABA-A Receptor Antagonists; gamma-Aminobutyric Acid; Hydrogen-Ion Concentration; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Male; Neurons; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley | 2014 |